source
- FDA approves Merck’s first oral PCSK9 inhibitor, marking a first for the drug classThe U.S. Food and Drug Administration has granted approval to Merck for its oral PCSK9 inhibitor, the first drug of this type to receive such clearance. The approval represents a milestone because…
- UnitedHealth beats Q2 forecasts but warns rising insurance costs will strain employersUnitedHealth Group reported second-quarter results that exceeded analysts' expectations, lifting its shares modestly. Despite the upbeat earnings, executives highlighted that medical expenses for…